Cargando…
Broadly Reactive Human Monoclonal Antibodies Targeting the Pneumococcal Histidine Triad Protein Protect against Fatal Pneumococcal Infection
Streptococcus pneumoniae remains a leading cause of bacterial pneumonia despite the widespread use of vaccines. While vaccines are effective at reducing the incidence of most serotypes included in vaccines, a rise in infection due to nonvaccine serotypes and moderate efficacy against some vaccine se...
Autores principales: | Huang, Jiachen, Gingerich, Aaron D., Royer, Fredejah, Paschall, Amy V., Pena-Briseno, Alma, Avci, Fikri Y., Mousa, Jarrod J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091081/ https://www.ncbi.nlm.nih.gov/pubmed/33649050 http://dx.doi.org/10.1128/IAI.00747-20 |
Ejemplares similares
-
Prediction and Validation of Immunogenic Domains of Pneumococcal Proteins Recognized by Human CD4(+) T Cells
por: van de Garde, Martijn D. B., et al.
Publicado: (2019) -
A Novel, Multiple-Antigen Pneumococcal Vaccine Protects against Lethal Streptococcus pneumoniae Challenge
por: Chan, Win-Yan, et al.
Publicado: (2019) -
Corrected and Republished from: “A Novel, Multiple-Antigen Pneumococcal Vaccine Protects against Lethal Streptococcus pneumoniae Challenge”
por: Chan, Win-Yan, et al.
Publicado: (2022) -
Development of Opsonic Mouse Monoclonal Antibodies against Multidrug-Resistant Enterococci
por: Kalfopoulou, Ermioni, et al.
Publicado: (2019) -
Identification and Characterization of Human Monoclonal Antibodies for Immunoprophylaxis against Enterotoxigenic Escherichia coli Infection
por: Giuntini, Serena, et al.
Publicado: (2018)